CL2018001138A1 - Un método ex vivo para probar la respuesta celular de las poblaciones de células primarias a una droga o combinación de drogas - Google Patents

Un método ex vivo para probar la respuesta celular de las poblaciones de células primarias a una droga o combinación de drogas

Info

Publication number
CL2018001138A1
CL2018001138A1 CL2018001138A CL2018001138A CL2018001138A1 CL 2018001138 A1 CL2018001138 A1 CL 2018001138A1 CL 2018001138 A CL2018001138 A CL 2018001138A CL 2018001138 A CL2018001138 A CL 2018001138A CL 2018001138 A1 CL2018001138 A1 CL 2018001138A1
Authority
CL
Chile
Prior art keywords
drug
cell populations
artificial
environment
test
Prior art date
Application number
CL2018001138A
Other languages
English (en)
Inventor
Nobell Juan Antonio Ballesteros
Ramos Daniel Primo
Ghia Paolo Prospero
Oquillas Ana Belén Espinosa
Guillén Julián Gorrochategui
Mateos Alicia Robles
Campo Pilar Hernández
Teresa Bennett
Santiago Grisolía Calle
Original Assignee
Vivia Biotech Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vivia Biotech Sl filed Critical Vivia Biotech Sl
Publication of CL2018001138A1 publication Critical patent/CL2018001138A1/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C12N5/0694—Cells of blood, e.g. leukemia cells, myeloma cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/40—Nucleotides, nucleosides, bases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/2302—Interleukin-2 (IL-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/2304—Interleukin-4 (IL-4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/2306—Interleukin-6 (IL-6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/231—Interleukin-10 (IL-10)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/2313—Interleukin-13 (IL-13)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/2315—Interleukin-15 (IL-15)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/2321—Interleukin-21 (IL-21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998—Proteins not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999—Small molecules not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/30—Coculture with; Conditioned medium produced by tumour cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C12N2503/02—Drug screening
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2513/00—3D culture

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

LA INVENCIÓN SE REFIERE A UN MÉTODO PARA PRODUCIR UN ENTORNO ARTIFICIAL DE POBLACIONES DE CÉLULAS PRIMARIAS, PARTICULARMENTE UN ENTORNO TUMORAL ARTIFICIAL DE POBLACIONES DE CÉLULAS TUMORALES PRIMARIAS Y SU USO EN UN MÉTODO EX VIVO PARA EVALUAR LA RESPUESTA CELULAR DE POBLACIONES DE CÉLULAS TUMORALES PRIMARIAS A UN FÁRMACO O DROGAS. EL MÉTODO DE LA INVENCIÓN COMPRENDE LA INCUBACIÓN DE LAS CÉLULAS TUMORALES PRIMARIAS CON EL ENTORNO DEL TUMOR ARTIFICIAL Y EL FÁRMACO O LOS FÁRMACOS Y ANALIZAR LA RESPUESTA DE LAS POBLACIONES DE CÉLULAS TUMORALES PRIMARIAS. LA INCUBACIÓN DE LAS CÉLULAS TUMORALES PRIMARIAS CON EL ENTORNO TUMORAL ARTIFICIAL, MEJORA LA VIABILIDAD DE DICHAS CÉLULAS TUMORALES Y / O INDUCE MAYORES NIVELES DE PROLIFERACIÓN DE CÉLULAS TUMORALES Y, EN CONSECUENCIA, AUMENTA LA SENSIBILIDAD Y PRECISIÓN DE LA PRUEBA CON RESPECTO A LOS FÁRMACOS ENSAYADOS.
CL2018001138A 2015-11-04 2018-04-27 Un método ex vivo para probar la respuesta celular de las poblaciones de células primarias a una droga o combinación de drogas CL2018001138A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562250687P 2015-11-04 2015-11-04

Publications (1)

Publication Number Publication Date
CL2018001138A1 true CL2018001138A1 (es) 2018-10-12

Family

ID=57421814

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2018001138A CL2018001138A1 (es) 2015-11-04 2018-04-27 Un método ex vivo para probar la respuesta celular de las poblaciones de células primarias a una droga o combinación de drogas

Country Status (14)

Country Link
US (1) US20190212325A1 (es)
EP (1) EP3371595B1 (es)
JP (1) JP6774685B2 (es)
KR (1) KR20180070603A (es)
CN (1) CN108351345B (es)
AU (1) AU2016348722A1 (es)
BR (1) BR112018008928A2 (es)
CA (1) CA3003347A1 (es)
CL (1) CL2018001138A1 (es)
HK (1) HK1258451A1 (es)
IL (1) IL259013A (es)
MX (1) MX2018005228A (es)
SG (1) SG11201803461RA (es)
WO (1) WO2017077046A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111089977A (zh) * 2019-12-30 2020-05-01 浙江科途医学科技有限公司 一种利用类器官检测溶瘤病毒有效性的方法
CN117192115A (zh) * 2023-11-03 2023-12-08 赛德特(北京)生物工程有限公司 检测t淋巴细胞免疫活性的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2260097B1 (en) * 2008-03-12 2017-04-26 Sanofi Pasteur VaxDesign Corporation Disease model incorporation into an artificial immune system (ais)
TW201024733A (en) * 2008-09-26 2010-07-01 Sanofi Aventis Methods for determining sodium-proton-exchanger ligand efficiency
WO2010120329A1 (en) * 2009-04-15 2010-10-21 The University Of Medicine And Dentistry Of New Jersey Reconstituted tumor microenvironment for anticancer drug development
RU2636614C2 (ru) * 2009-05-19 2017-11-24 Вивия Байотек С.Л. Способы персонализированного медицинского тестирования ex vivo на гематологические новообразования
WO2014035668A1 (en) * 2012-08-28 2014-03-06 The Brigham And Women's Hospital, Inc. Functional assay for cancer recurrence and malignant potential
US9958432B2 (en) * 2013-09-20 2018-05-01 Lynx Biosciences, Inc. Cellular cis-co-culture systems for analysis

Also Published As

Publication number Publication date
JP2018533728A (ja) 2018-11-15
JP6774685B2 (ja) 2020-10-28
MX2018005228A (es) 2018-08-15
CN108351345A (zh) 2018-07-31
AU2016348722A1 (en) 2018-05-17
IL259013A (en) 2018-06-28
US20190212325A1 (en) 2019-07-11
CA3003347A1 (en) 2017-05-11
CN108351345B (zh) 2021-11-30
EP3371595A1 (en) 2018-09-12
BR112018008928A2 (pt) 2019-04-30
SG11201803461RA (en) 2018-05-30
WO2017077046A1 (en) 2017-05-11
KR20180070603A (ko) 2018-06-26
HK1258451A1 (zh) 2019-11-15
EP3371595B1 (en) 2019-12-25

Similar Documents

Publication Publication Date Title
CY1123823T1 (el) Βελτιωμενες συνθεσεις τ κυτταρων
GB2570593A (en) Methods relating to intestinal organ-on-a-chip
ECSP17016797A (es) Indazoles sustituidos con benzilo como inhibidores de bub1
CL2017002422A1 (es) Derivados de maitansinoide, conjugados de los mismos, y métodos de uso.
AR094375A1 (es) Métodos de uso de inhibidores del ciclo celular para modular una o más propiedades de un cultivo celular
CL2019001378A1 (es) Microcompartimento celular y métodos de preparación.
CL2016002004A1 (es) Anticuerpos anti-jagged1 y métodos de uso
BR112019006865A2 (pt) caspases induzíveis e métodos para uso
PE20171135A1 (es) Metodos para seleccionar una linea de celulas t y donador de la misma para terapia celular adoptiva
EA201692425A1 (ru) Модифицированные биополимеры и способы их получения и использования
AR105602A1 (es) Medio de cultivo celular suplementado con taurina y métodos de utilización
BR112016015105A2 (pt) Conjugados var2csa-droga
SV2011003888A (es) Compuestos que expanden las celulas madre hematopoieticas
EA201790010A1 (ru) Гамма-дельта t-клетки и их применение
BR112016019677A2 (pt) método de preparação de um condensado celular in vitro, condensado celular, método de preparação de uma estrutura tissular tridimensional e suporte de cultura semelhante a gel
CL2018001775A1 (es) Unidades de administración de agroquímicos de liberación controlada, su fabricación y uso
BR112017012210A2 (pt) solução conservante de célula, uso da mesma e método de produção de solução conservante de célula
CL2017002101A1 (es) Dispositivo, plataforma y ensayo para evaluación de células
MX366369B (es) Metodo para un ensayo de deteccion de farmacos basado en celulas y el uso del mismo.
CY1123718T1 (el) Κυτταροκαλλιεργεια
BR112017017886A2 (pt) gerando populações de células endoteliais arteriais
BR112016028512A2 (pt) métodos de cultivo por perfusão e seu uso
CL2019002323A1 (es) Anticuerpo dirigido a il-13ra2 y su uso.
CL2020000734A1 (es) Expansión y uso de fracciones de células nk ampliadas.
MA51107A (fr) Cellules souches et progénitrices hématopoïétiques humaines cd34+ modifiées par crispr-cas9 et utilisations associées